搜索
Search
这是描述信息

API Division

/
/
Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.

Introduction of API Division

Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.

Description:
Description:
Information

Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.

 

Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. (FFPC), established in 1979, was 100% acquired by Livzon Pharmaceutical Group Inc. in 2004, with the purpose of developing it into a first–class fermented API production center and research & development (R&D) center.

 

FFPC has 2 manufacturing sites in Fujian province, which have modern equipment, and advanced fermentation and extraction technologies. The facilities been approved by USFDA and EUGMP and received SGMP and CGMP certifications. The main products produced by FFPC are vancomycin HCl, teicoplanin, milbemycin oxime, and kanamycin acid sulphate. Vancomycin HCl and teicoplanin have obtained CEP certificates, and kanamycin mono sulfate and kanamycin acid sulfate have passed World Health Organization (WHO) inspection.

 

1

Introduction of API Division

Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China    Tel: 0756-8135888    

©2021 Livzon  粤ICP备05025993号  Support:300.cn

Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China  

©2021 Livzon   粤ICP备05025993号  

 Support:300.cn